-
Brain antioxidant levels can detect progression of Alzheimer’s Disease, study states
- October 14, 2018
- Posted by: PharmaScroll
- Category:
No Comments -
Novel Biomarker for diagnosis of Alzheimer’s identified by researchers
- September 5, 2018
- Posted by: PharmaScroll
- Category:
-
Phase 1b data for alzheimer’s disease treatment aducanumab announced
- August 29, 2018
- Posted by: PharmaScroll
- Category:
-
Roche receives FDA’s breakthrough status for its new Alzheimer’s biomarker
- July 25, 2018
- Posted by: PharmaScroll
- Category:
-
Bill Gates invests $30m on affordable Alzheimer’s test
- July 20, 2018
- Posted by: PharmaScroll
- Category:
-
Antiherpetic medications reduce Alzheimer’s dementia risk by a factor of 10, says latest research
- July 17, 2018
- Posted by: PharmaScroll
- Category:
-
Scientists discover genesis of Alzheimer’s, call it a “Big Bang” for the disease
- July 12, 2018
- Posted by: PharmaScroll
- Category:
-
ANAVEX®2-73 approved to initiate trial for Alzheimer’s & Parkinson’s Disease
- July 10, 2018
- Posted by: PharmaScroll
- Category:
-
Eisai and Biogen report positive results for Alzheimer’s drug BAN2401
- July 8, 2018
- Posted by: PharmaScroll
- Category:
-
ORYZON announces First Patients in Alzheimer’s trial in UK
- June 27, 2018
- Posted by: PharmaScroll
- Category: